MODEL VERDICT
Cryoport, Inc. (CYRX)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
Each row records the model's monthly assessment. High Conviction = the model detected notable undervaluation vs peers. Neutral = no notable divergence was found. The return column shows the actual price change over 90 days for reference. This is a quantitative observation log — not investment advice.
| Date | Assessment | Score | Price | Status | 90d Fwd Return |
|---|---|---|---|---|---|
| May 1, 2026 | NEUTRAL | 0.53 | $10.35 | CURRENT | — |
| Apr 24, 2026 | NEUTRAL | 0.53 | $10.59 | CURRENT | — |
| Apr 17, 2026 | NEUTRAL | 0.53 | $10.35 | CURRENT | — |
| Apr 16, 2026 | NEUTRAL | 0.53 | $10.07 | CURRENT | — |
| Apr 10, 2026 | NEUTRAL | 0.53 | $9.67 | CURRENT | — |
Historical model observations for research purposes only. Past quantitative patterns do not predict future results. Not a recommendation to buy, sell, or hold any security.
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 6 industry peers | $2.42 | -76.6% | 4% | B | Data |
| Price / Sales 6 industry peers | $5.31 | -48.7% | 3% | B | Model Driven |
| Weighted Output Blended model output | $14.01 | +35.3% | 100% | 48 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 14.90 | 4.99 | 2.11 | 72.02 | 25.31 |
| P/B Ratio | 3.57 | 4.23 | 0.94 | 8.07 | 2.50 |
| P/S Ratio | 10.60 | 12.21 | 1.63 | 21.51 | 7.80 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates CYRX's fair value at $14.01 vs the current price of $10.35, implying +35.3% upside potential. Model verdict: Significantly Undervalued. Confidence: 48/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $14.01 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%). Monte Carlo simulation (10,000 iterations) gives a range of $3.49 (P10) to $18.11 (P90), with a median of $10.50.
CYRX's current P/E of -4.7x compares to the industry median of 29.6x (4 peers in the group). This represents a -115.9% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
18 analysts cover CYRX with a consensus rating of Buy. The consensus price target is $12.50 (range: $12.50 — $12.50), implying +20.8% upside from the current price. Grade breakdown: Strong Buy (0), Buy (14), Hold (4), Sell (0), Strong Sell (0).
The model confidence score is 48/100, based on: data completeness (6), peer quality (25), historical depth (20), earnings stability (5), and model agreement (2). Cyclicality penalty: --10 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for CYRX.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.